Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4
A. Panasiuk et al., Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4, HEP-GASTRO, 48(39), 2001, pp. 818-822
Background/Aims: Blood platelets-are;cells that quite often undergo damage
in chronic liver diseases. Endotoxemia and hyperkinetic circulation influen
ce platelets in an active manner. The role sf platelets in the development
of hepatitis and liver fibrosis is speculative. The aim of the study was to
determine the influence of chronic liver diseases on platelets morphologic
parameters, their secretory activity and beta -selectin expression.
Methodology: The examination-was completed in the group of 29 patients with
chronic hepatitis and 27 with liver cirrhosis of postinflammatory etiology
(HBV HCV); Liver biopsies were carried out in all control group. Platelets
morphological parameters (number, volume,platelet crit, micro- and macro-t
hrombocyte fraction) were estimated. beta -thromboglobulin concentration an
d platelet:factor 4 in blood serum as well as beta -selectin expression on
resting platelets and after thrombin activation were alsoexamined.
Results:Number, volume, and platelet crit decreased with the advancement of
a liver disease. Megathrombocyte fraction increased inversely with the sev
erity of liver damage. The concentration of beta -thromboglobulin and plate
let factor 4 alpha -granule contents in blood serum was higher 2- and 7-tim
es, respectively than in healthy controls. beta -selectin expression on res
ting platelets was considerably higher. After stimulation with thrombin, be
ta -selectin expression was equal (chronic hepatitis) or: higher (liver cir
rhosis)than in the control.
Conclusions: There are changes of platelet megathrombocyte fraction increas
e, that occur in chronic liver diseases. Thrombocytes in chronic liver dise
ases and Liver cirrhosis are more activated. Platelet-sensitivity to stimul
i in these ailments is higher (liver cirrhosis) than in the healthy control
s.